Audit committee

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Thoughtworks Holding, Inc. - TWKS

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Thoughtworks Holding, Inc. (“Thoughtworks” or the “Company”) (NASDAQ: TWKS).

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Thoughtworks Holding, Inc. (“Thoughtworks” or the “Company”) (NASDAQ: TWKS).
  • The investigation concerns whether Thoughtworks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).
  • The investigation concerns whether Chemours and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

CoreCivic Appoints Catherine Hernandez-Blades and Alexander R. Fischer to its Board of Directors; CoreCivic Also Announces Planned Retirement of Long-Term Board Member Donna Alvarado

Retrieved on: 
Thursday, March 7, 2024

Both Ms. Hernandez-Blades and Mr. Fischer are expected to join various board committees in the future.

Key Points: 
  • Both Ms. Hernandez-Blades and Mr. Fischer are expected to join various board committees in the future.
  • "We are pleased to have Catherine and Alex join our Board of Directors," said Damon Hininger, CoreCivic's President and Chief Executive Officer.
  • "Catherine brings decades of executive leadership experience in government relations, communications, and marketing in both the private and the public sectors.
  • Catherine also provides community support as a board member at several non-profits.

ADTN INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages ADTRAN Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – ADTN

Retrieved on: 
Thursday, March 7, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22898 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ

Retrieved on: 
Thursday, March 7, 2024

New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, SAGAR”) (the “Company”) received a Nasdaq Hearing Withdrawal letter (“Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) on March 6, 2024.

Key Points: 
  • New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, SAGAR”) (the “Company”) received a Nasdaq Hearing Withdrawal letter (“Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) on March 6, 2024.
  • On November 27, 2023, the Company filed its delinquent Form 10-Q for the period ended March 31, 2023, disclosing total shares outstanding of 49,346,337.
  • At the time of the acquisition, the Company’s total shares outstanding was 1,471,337 shares.
  • Nasdaq will file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission when all internal procedural periods have run.

QuantaSing Announces Unaudited Financial Results for the Second Quarter of Fiscal Year 2024

Retrieved on: 
Thursday, March 7, 2024

BEIJING, March 07, 2024 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced its unaudited financial results for the second quarter of the fiscal year ending June 30, 2024 (the “second quarter of FY 2024”, which refers to the quarter from October 1, 2023 to December 31, 2023).

Key Points: 
  • BEIJING, March 07, 2024 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced its unaudited financial results for the second quarter of the fiscal year ending June 30, 2024 (the “second quarter of FY 2024”, which refers to the quarter from October 1, 2023 to December 31, 2023).
  • Revenues for the second quarter of FY 2024 were RMB980.5 million (US$138.1 million), representing an increase of 12.8% from the first quarter of the fiscal year ending June 30, 2024 (the “first quarter of FY 2024”) and an increase of 24.7% from the second quarter of the fiscal year ended June 30, 2023 (the “second quarter of FY 2023”).
  • Net income for the second quarter of FY 2024 was RMB107.6 million (US$15.2 million), compared with RMB66.7 million in the first quarter of FY 2024, and a net loss of RMB41.4 million in the second quarter of FY 2023.
  • Adjusted net income2 for the second quarter of FY 2024 was RMB103.9 million (US$14.6 million), compared with RMB94.0 million in the first quarter of FY 2024, and RMB21.8 million in the second quarter of FY 2023.

MIND CTI Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, March 6, 2024

YOQNEAM, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- MIND C.T.I. LTD. – (NasdaqGM: MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product based solutions for service providers, unified communications analytics and call accounting solutions for enterprises as well as enterprise messaging solutions, today announced results for its fourth quarter of 2023 and its full year ended December 31, 2023.

Key Points: 
  • The following will summarize our business in the fourth quarter of 2023 and provide a more detailed review of the financial results for the quarter and for the full year.
  • Operating income of $ 1.2 million, or 21% of total revenue, compared to $1.2 million, or 23% of revenue in the fourth quarter of 2022.
  • Net income of $1.4 million, or $0.06 per share, compared to $1.3 million, or $0.06 per share in the fourth quarter of 2022.
  • Cash flow from operating activities of $0.7 million, compared to $1.4 million in the fourth quarter of 2022.

Zenas BioPharma Appoints Patricia Allen to its Board of Directors

Retrieved on: 
Wednesday, March 6, 2024

Ms. Allen joins the Zenas Board of Directors with over 20 years of experience leading finance, investor relations, business development, human resources, operations and IT at global public and private biotechnology companies.

Key Points: 
  • Ms. Allen joins the Zenas Board of Directors with over 20 years of experience leading finance, investor relations, business development, human resources, operations and IT at global public and private biotechnology companies.
  • “We are pleased to welcome Patty to our Board of Directors,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma.
  • “She has successfully led cross-organizational functions and served on the board of directors of both private and public global biotechnology companies.
  • Prior to Vividion, Ms. Allen was the Chief Financial Officer at Zafgen, Inc. (now Larimer Therapeutics).

Grupo Aeroportuario del Pacifico Reports in February 2024 A Passenger Traffic Increase of 1.7% Compared to 2023

Retrieved on: 
Tuesday, March 5, 2024

The load factors for the month went from 78.3% in February 2023 to 81.7% in February 2024.

Key Points: 
  • The load factors for the month went from 78.3% in February 2023 to 81.7% in February 2024.
  • Grupo Aeroportuario del Pacífico, S.A.B.
  • The words “anticipates”, “believes”, “estimates”, “expects”, “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements.
  • The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors.

The Chefs’ Warehouse, Inc. Reaches Cooperation Agreement with Legion Partners Asset Management

Retrieved on: 
Monday, March 4, 2024

RIDGEFIELD, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (the “Company”) (Nasdaq: CHEF), a premier distributor of specialty food products in the United States, the Middle East and Canada, announced today that it has entered into an agreement (the “Cooperation Agreement”) with Legion Partners Asset Management, LLC and certain of its affiliates (collectively, “Legion Partners”). Legion Partners beneficially owns approximately 3.3% of the Company’s outstanding common stock.

Key Points: 
  • RIDGEFIELD, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (the “Company”) (Nasdaq: CHEF), a premier distributor of specialty food products in the United States, the Middle East and Canada, announced today that it has entered into an agreement (the “Cooperation Agreement”) with Legion Partners Asset Management, LLC and certain of its affiliates (collectively, “Legion Partners”).
  • Legion Partners beneficially owns approximately 3.3% of the Company’s outstanding common stock.
  • The Company has agreed to nominate Mr. Peretz and Ms. Weinstein for election at the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
  • Further, as provided in the Cooperation Agreement, a third new independent director, Lester Owens, was appointed to the Board on March 4, 2024 and will be nominated for election at the Company’s 2024 Annual Meeting.